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not yet apparent, and recovery rates based on objective markers are
high. We intend to continue follow-up for the next two to five
years, while looking for evidence of any long-term sequelae.
The utility of endomyocardial biopsy after smallpox vaccination
is uncertain. Given the inherent risks and low diagnostic yield of
endomyocardial biopsy (1,4), as well as the high likelihood of full
objective recovery after smallpox vaccine-associated myopericardi-
tis (3), we would be remiss to recommend a potentially harmful
procedure in all patients with depressed left ventricular function.
Although there has been one case of eosinophilic myocarditis
that improved shortly after receiving corticosteroids (5), this one
case is insufficient to conclude that corticosteroids will always be
beneficial, even when eosinophils are seen on biopsy. However, the
possibility that corticosteroids may uniquely benefit patients with
eosinophilic myocarditis does warrant continued evaluation.
Therefore, although we support endomyocardial biopsy in patients
with symptomatic moderate or worse left-ventricular dysfunction
related temporally to smallpox vaccination, we caution that every
case must be considered individually.
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Pacemaker Complication
During Magnetic Resonance Imaging
The article by Martin et al. (1) suggesting that magnetic resonance
imaging (MRI) examinations are safe in qualified pacemaker
patients should lead to improved care, especially for cancer
patients. Encouraged by this article, we have taken two patients
into a Signa LX EchoSpeed 1.5-T MRI (GE Medical Systems,
Milwaukee, Wisconsin). Our second patient experienced difficul-
ties not previously noted, demonstrating the need for continued
caution when performing these exams.
A 48-year-old man with a left-sided, dual-chamber pacemaker
placed on August 1, 1997, for neurogenic syncope (Thera DR
7960i, Medtronic Corp., Minneapolis, Minnesota) had metastatic
multiple myeloma and significant pain. The MRI was performed
to evaluate lower extremity neurologic deficits after attempted
intrathecal catheter implantation.
The thoracic and lumbar spine regions were evaluated by
sagittal fast spin echo (FSE) T2-weighted pulse sequences with fat
saturation and pre/post contrast T1-weighted FSE pulse sequences
in the sagittal and axial planes. Compared to previous computed
tomography (CT) myelogram, MRI revealed more extensive cord
compression at T9–10 from epidural tumor. The MRI demon-
strated no epidural hematoma, possibly preventing an unnecessary
laminectomy. A CT examination performed one month previ-
ously, because of pacemaker contraindication to MRI, demon-
strated no epidural involvement.
Pacemaker evaluation immediately before MRI showed ade-
quate battery voltage and impedance (Fig. 1) with DDDR pacing
(lower rate 60, upper sensor and tracking rates 135 beats/min).
M.A.R. (an anesthesiologist “facile in the ways of pacemaker
programming”) disabled pacemaker rate responsiveness and mon-
itored the patient with pulse oximetry plethysmography and
electrocardiography (Millennia 3155 MVS monitor, In Vivo Re-
search, Orlando, Florida). This monitor has no pacemaker artifact
enhancement in the remote (MRI) mode.
Upon entering the MRI room, pacemaker magnet mode was
activated (DOO pacing, 85 beats/min) until patient alignment
with the MRI tunnel (heart rate returned to 74 beats/min). During
MRI, pacing appeared to remain in DDD mode, with heart rates
between 68 and 82 beats/min. Occasional pseudofusion beats were
noted, but the ECG tracing was unreliable during MRI sequences.
PVCs were noted during and between MRI scan cycles. No
medication was given, and the patient did not complain of
palpitations or chest pain (although he had back pain). He was
quickly removed from the MRI upon completion of the 1.5-h
exam.
Immediate pacemaker interrogation revealed onset of elective
replacement (ERI) with a programming change to VVI pacing at 65
beats/min despite normal battery voltage and impedance (Fig. 2).
This change eliminated all pacemaker diagnostic data storage. The
“STATUS RESET” function in the programmer returned the pace-
Figure 1. Battery and pacemaker lead data from a Medtronic Thera Model
7960i dual-chamber pacemaker immediately before magnetic resonance
imaging of the thoracic and lumbar spine in a 1.5-T magnetic resonance
imager. The battery showed acceptable voltage and impedance with a
21-month life expectancy.
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maker to dual-chamber function, and no other abnormalities were
found.
It is unclear why our patient’s pacemaker detected an ERI
condition. Medtronic Thera platforms (including Prodigy, Preva,
Kappa 400, and Insynch 8040) can be especially sensitive to
electromagnetic interference signals entering via the telemetry coil,
which might account for our observation in this case. Although no
inappropriate ERI was found in the Martin et al. (1) series, which
included 12 of these platforms (but only one Thera device), no
thoracic spine MRI examinations were performed.
This outcome reminds us that significant pacemaker problems
might still occur during MRI, despite the experience of Martin et
al. (1). Although their report will likely permit better care of
pacemaker patients, the caveat that special care of these patients
appears necessary. We believe that recommendations from Martin
et al. (1) should be strengthened. Rather than simply available, a
physician who is “facile in the ways of pacemaker programming”
should be present to monitor the patient, as suggested by Gimbel
and Kanal (2). Additionally, the entire team caring for patients in
the MRI suite needs to be prepared to quickly and immediately
remove the patient from the MRI should a significant problem be
discovered.
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REPLY
We thank Dr. Rozner and colleagues for their interest in our work
(1). They found that a Medtronic Thera DR 7960i pacemaker
demonstrated an elective replacement indicator upon interrogation
of the device immediately after magnetic resonance imaging
(MRI). This phenomenon is neither unexpected nor alarming.
Many pacemakers will respond with this warning after an exposure
to intense electromagnetic interference. Examples of this exposure
include direct current cardioversion, radiofrequency ablation, elec-
trocautery, and MRI. This response is unrelated to the battery
voltage or impedance but rather occurs because of a brief power
interruption. Magnetic resonance imaging can cause this behavior
when the telemetry coil or leads themselves are driven by the
radiofrequency output of the MRI, which can result in a parasitic
capacitance for brief instances. The solution, when this occurs, is
to reset the pulse generator. Newer pacemakers are more resistant
to such interference but also can demonstrate this problem.
With respect to their comments, several observations are rele-
vant. The statement that a “pacemaker-facile physician” be present
rather than available is consistent with our practice and our
recommendations. During all MRI examinations involving pace-
maker and implantable-cardiovertor defibrillator patients at Okla-
homa Heart Institute, an electrophysiologist is present and observ-
ing all available data from the start of the scan through completion
of the post exam interrogation. We concur wholeheartedly that
this extra step is mandatory to the performance of these studies.
Since the publication of our article (1), we have had the
opportunity to expand our pacemaker/MRI database to include a
total of 87 patients with 156 leads. We have continued to observe
similar but subtle threshold changes in a portion of leads subjected
to the levels of electromagnetic interference found at 1.5-T, but
none of these threshold changes have been beyond the safe
programming limits of the pulse generators.
We stand by our original conclusions. Performance of MRI in
appropriately selected, nonpacemaker-dependent patients can be
accomplished with an acceptable safety profile. Precautions must
include continuous monitoring of the patient with ECG and
intermittent voice contact, resuscitation equipment on standby,
adequate personnel to move and resuscitate the patient should the
need arise, and the presence of a person facile in pacemaker
interrogation and programming.
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Figure 2. Battery and lead data obtained immediately after magnetic
resonance imaging. Despite acceptable voltage and impedance, the pace-
maker shows “replace pacemaker,” rather than “OK,” for battery status.
Thus, the pacemaker changed from DDD pacing (lower rate 60, upper
tracking rate 135 beats/min) to VVI at 65 beats/min. For this pacemaker,
replacement is not needed until battery voltage is less than 2.62 volts with
impedance 3,000 ohms.
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